List of bibliographic references
Number of relevant bibliographic references: 5.
List of associated KwdEn.i
Nombre de
documents | Descripteur |
|---|
| 3 | Adult |
| 3 | Aged |
| 3 | Female |
| 3 | Humans |
| 3 | Male |
| 3 | Middle Aged |
| 2 | Administration, Intravenous |
| 2 | Antineoplastic Combined Chemotherapy Protocols (administration & dosage) |
| 2 | Antineoplastic Combined Chemotherapy Protocols (adverse effects) |
| 2 | Cyclophosphamide (administration & dosage) |
| 2 | Leukemia, Lymphocytic, Chronic, B-Cell (drug therapy) |
| 2 | Rituximab (administration & dosage) |
| 2 | Rituximab (adverse effects) |
| 2 | Rituximab (pharmacokinetics) |
| 2 | Treatment Outcome |
| 2 | Vidarabine (administration & dosage) |
| 2 | Vidarabine (analogs & derivatives) |
| 1 | Administration, Cutaneous |
| 1 | Adolescent |
| 1 | Aged, 80 and over |
| 1 | Antineoplastic Agents (administration & dosage) |
| 1 | Antineoplastic Agents (adverse effects) |
| 1 | Antineoplastic Agents (pharmacokinetics) |
| 1 | Antineoplastic Agents, Alkylating (administration & dosage) |
| 1 | Antineoplastic Agents, Alkylating (adverse effects) |
| 1 | Antineoplastic Agents, Alkylating (pharmacokinetics) |
| 1 | Antineoplastic Combined Chemotherapy Protocols |
| 1 | Antineoplastic Combined Chemotherapy Protocols (pharmacokinetics) |
| 1 | Cyclophosphamide (adverse effects) |
| 1 | Cyclophosphamide (pharmacokinetics) |
| 1 | Cyclophosphamide (therapeutic use) |
| 1 | Disease-Free Survival |
| 1 | Drug Administration Schedule |
| 1 | Drug-Related Side Effects and Adverse Reactions (classification) |
| 1 | Drug-Related Side Effects and Adverse Reactions (pathology) |
| 1 | Fusion Proteins, bcr-abl (genetics) |
| 1 | Imatinib Mesylate (administration & dosage) |
| 1 | Imatinib Mesylate (adverse effects) |
| 1 | Imidazoles (administration & dosage) |
| 1 | Imidazoles (adverse effects) |
| 1 | Injections, Subcutaneous |
| 1 | Kaplan-Meier Estimate |
| 1 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive (drug therapy) |
| 1 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive (genetics) |
| 1 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive (pathology) |
| 1 | Patient Preference |
| 1 | Philadelphia Chromosome (drug effects) |
| 1 | Pyridazines (administration & dosage) |
| 1 | Pyridazines (adverse effects) |
| 1 | Vidarabine (adverse effects) |
| 1 | Vidarabine (pharmacokinetics) |
| 1 | Vidarabine (therapeutic use) |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Canada/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/Canada/Analysis/Author.i -k "Sarit Assouline"
HfdIndexSelect -h $EXPLOR_AREA/Data/Canada/Analysis/Author.i \
-Sk "Sarit Assouline" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Canada/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Canada
|étape= Analysis
|type= indexItem
|index= Author.i
|clé= Sarit Assouline
}}
| This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024 |  |
